191 related articles for article (PubMed ID: 31163210)
21. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
Terleckyj I; Sonsalla PK
J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
[TBL] [Abstract][Full Text] [Related]
22. Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.
Tsuji T; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N
Neurochem Res; 2009 Apr; 34(4):764-74. PubMed ID: 18946735
[TBL] [Abstract][Full Text] [Related]
23. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
Fletcher PJ; Rizos Z; Noble K; Soko AD; Silenieks LB; Lê AD; Higgins GA
Neuropharmacology; 2012 Jun; 62(7):2288-98. PubMed ID: 22342986
[TBL] [Abstract][Full Text] [Related]
24. Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice.
Amodeo DA; Jones JH; Sweeney JA; Ragozzino ME
Autism Res; 2014 Oct; 7(5):555-67. PubMed ID: 24894823
[TBL] [Abstract][Full Text] [Related]
25. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
26. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
[TBL] [Abstract][Full Text] [Related]
27. Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Piao YS; Hall FS; Moriya Y; Ito M; Ohara A; Kikura-Hanajiri R; Goda Y; Lesch KP; Murphy DL; Uhl GR; Sora I
Behav Pharmacol; 2015 Jun; 26(4):345-52. PubMed ID: 25794333
[TBL] [Abstract][Full Text] [Related]
28. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
Benaliouad F; Kapur S; Rompré PP
Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
[TBL] [Abstract][Full Text] [Related]
29. Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality.
Bronstein DM; Hong JS
J Pharmacol Exp Ther; 1995 Aug; 274(2):943-50. PubMed ID: 7636758
[TBL] [Abstract][Full Text] [Related]
30. Effects of long-term high-fat food or methamphetamine intake and serotonin 2C receptors on reversal learning in female rhesus macaques.
Perez Diaz M; Wilson ME; Howell LL
Neuropsychopharmacology; 2019 Feb; 44(3):478-486. PubMed ID: 30188516
[TBL] [Abstract][Full Text] [Related]
31. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
Nguyen EC; McCracken KA; Liu Y; Pouw B; Matsumoto RR
Neuropharmacology; 2005 Oct; 49(5):638-45. PubMed ID: 15939443
[TBL] [Abstract][Full Text] [Related]
32. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Herin DV; Liu S; Ullrich T; Rice KC; Cunningham KA
Psychopharmacology (Berl); 2005 Apr; 178(4):505-13. PubMed ID: 15765263
[TBL] [Abstract][Full Text] [Related]
33. The effects of the β1 antagonist, metoprolol, on methamphetamine-induced changes in core temperature in the rat.
Harrell R; Speaker HA; Mitchell SL; Sabol KE
Neurosci Lett; 2015 Nov; 609():81-6. PubMed ID: 26388403
[TBL] [Abstract][Full Text] [Related]
34. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Numachi Y; Ohara A; Yamashita M; Fukushima S; Kobayashi H; Hata H; Watanabe H; Hall FS; Lesch KP; Murphy DL; Uhl GR; Sora I
Eur J Pharmacol; 2007 Oct; 572(2-3):120-8. PubMed ID: 17673199
[TBL] [Abstract][Full Text] [Related]
35. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
Tata DA; Raudensky J; Yamamoto BK
Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
[TBL] [Abstract][Full Text] [Related]
36. Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study.
Steed E; Jones CA; McCreary AC
Behav Brain Res; 2011 Jun; 220(1):9-19. PubMed ID: 21262272
[TBL] [Abstract][Full Text] [Related]
37. alpha-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine.
Moore KA; Lichtman AH; Poklis A; Borzelleca JF
Drug Alcohol Depend; 1995 Aug; 39(2):83-9. PubMed ID: 8529536
[TBL] [Abstract][Full Text] [Related]
38. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
[TBL] [Abstract][Full Text] [Related]
39. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.
Hedges DM; Obray JD; Yorgason JT; Jang EY; Weerasekara VK; Uys JD; Bellinger FP; Steffensen SC
Neuropsychopharmacology; 2018 May; 43(6):1405-1414. PubMed ID: 29185481
[TBL] [Abstract][Full Text] [Related]
40. Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus Monkeys.
Perez Diaz M; Andersen ML; Rice KC; Howell LL
Neuropsychopharmacology; 2017 Jun; 42(7):1531-1538. PubMed ID: 27986974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
